scholarly journals Orientation of endothelial cell division is regulated by VEGF signaling during blood vessel formation

Blood ◽  
2006 ◽  
Vol 109 (4) ◽  
pp. 1345-1352 ◽  
Author(s):  
Gefei Zeng ◽  
Sarah M. Taylor ◽  
Janet R. McColm ◽  
Nicholas C. Kappas ◽  
Joseph B. Kearney ◽  
...  

Abstract New blood vessel formation requires the coordination of endothelial cell division and the morphogenetic movements of vessel expansion, but it is not known how this integration occurs. Here, we show that endothelial cells regulate division orientation during the earliest stages of blood vessel formation, in response to morphogenetic cues. In embryonic stem (ES) cell–derived vessels that do not experience flow, the plane of endothelial cytokinesis was oriented perpendicular to the vessel long axis. We also demonstrated regulated cleavage orientation in vivo, in flow-exposed forming retinal vessels. Daughter nuclei moved away from the cleavage plane after division, suggesting that regulation of endothelial division orientation effectively extends vessel length in these developing vascular beds. A gain-of-function mutation in VEGF signaling increased randomization of endothelial division orientation, and this effect was rescued by a transgene, indicating that regulation of division orientation is a novel mechanism whereby VEGF signaling affects vessel morphogenesis. Thus, our findings show that endothelial cell division and morphogenesis are integrated in developing vessels by flow-independent mechanisms that involve VEGF signaling, and this cross talk is likely to be critical to proper vessel morphogenesis.

2002 ◽  
Vol 277 (19) ◽  
pp. 17281-17290 ◽  
Author(s):  
Gieri Camenisch ◽  
Maria Teresa Pisabarro ◽  
Daniel Sherman ◽  
Joe Kowalski ◽  
Mark Nagel ◽  
...  

Development ◽  
2015 ◽  
Vol 142 (17) ◽  
pp. 3058-3070 ◽  
Author(s):  
D. M. Barry ◽  
K. Xu ◽  
S. M. Meadows ◽  
Y. Zheng ◽  
P. R. Norden ◽  
...  

Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 3956-3956
Author(s):  
Guenther Eissner ◽  
Edward K. Geissler ◽  
Massimo Iacobelli ◽  
Reinhard Andreesen ◽  
Ernst Holler ◽  
...  

Abstract DF is a polydisperse mixture of single-stranded polydeoxyribunucleotides which is successfully used in the treatment of hepatic veno-occlusive disease and other endothelial disorders. Recent pre-clinical evidence suggests that DF might also have anti-neoplastic properties. We addressed the question whether this might be due to the prevention of tumor blood vessel formation (angiogenesis). The anti-angiogeneic potential of DF was tested in vitro (Matrigel™ tube formation and aortic ring assay) and in vivo (dorsal skin-fold chamber model). Our results show that DF quantitatively (100%) blocks tube formation of trans-differentiated human endothelial-like cells (ELC) at concentrations corresponding to pharmacologic DF blood levels (100 μg/mL). Similarly, the sprouting of rat aorta endothelial cells in Matrigel™ was prevented by nearly 100%, when DF was applied on a daily basis. In vivo tumor angiogenesis in a human gastric cancer (TMK-1) grown in skin-fold chambers (nude mice) was also attenuated on day 5 by DF, as measured by microvascular density. Although the exact mechanism of DF action remains to be elucidated, initial Western blotting results show that DF reduces phosphorylation-activation of p70S6 kinase, which is a key target in the PI3K/Akt/mTOR signaling pathway linked to endothelial cell and pericyte proliferation and activation. Taken together, our data suggest that while DF is known for its endothelium-protecting function, it also inhibits tumor blood vessel formation, and thus should be considered for further testing as an anticancer agent.


2019 ◽  
Vol 223 ◽  
pp. 115034 ◽  
Author(s):  
Catarina Oliveira ◽  
Sara Granja ◽  
Nuno M Neves ◽  
Rui L Reis ◽  
Fátima Baltazar ◽  
...  

2013 ◽  
Vol 33 (suppl_1) ◽  
Author(s):  
Zhong Liu ◽  
Ujala Rana ◽  
Baofeng Zhao ◽  
Qing R Miao

Nogo-B was previously identified as a protein that is expressed in endothelial cells and vascular smooth muscle cells. Nogo-A/B deficient mice show exaggerated neointimal proliferation and abnormal remodeling. Nogo-B receptor (NgBR) is a type I receptor, which was identified as a receptor specific for Nogo-B. Our previous work has shown that Nogo-B and its receptor (NgBR) are essential for chemotaxis and morphogenesis of endothelial cells in vitro and intersomitic vessel formation via Akt pathway in zebrafish. Our recent work reveals that NgBR is a critic membrane scaffold protein required for Ras translocation and activation, which is essential for VEGF-stimulated Ras-PI3K-Akt signaling pathway. Here, we further demonstrate the roles of NgBR in regulating primitive blood vessel formation in embryoid body culture systems and vasculature development in mouse embryo. Murine NgBR gene-targeting embryonic stem cells (ESC) were generated by homologous recombination approaches. Homozygous knockout of NgBR in ESC results in cell apoptosis. Heterozygous knockout of NgBR does not affect ESC cell survival, but reduces the formation and branching of primitive blood vessels in embryoid body culture systems. In addition, our preliminary results show that NgBR homozygous knockout mice are embryonic lethal happened at E6.5 or earlier, and endothelial cell specific NgBR knockout mice are embryonic lethal happened at E11.5 and have severe blood vessel formation defects in embryo. Mechanistically, NgBR has two potential regulatory roles during embryonic vasculature development. NgBR knockdown not only decreases both Nogo-B and VEGF-stimulated endothelial cell migration by abolishing Akt phosphorylation, but also impairs endothelial cell lineage commitment by delaying BMP4 production during the period of mesoderm formation. These results suggest that NgBR may be one of important genes coordinating the vasculature development.


Blood ◽  
2004 ◽  
Vol 103 (12) ◽  
pp. 4527-4535 ◽  
Author(s):  
Joseph B. Kearney ◽  
Nicholas C. Kappas ◽  
Catharina Ellerstrom ◽  
Frank W. DiPaola ◽  
Victoria L. Bautch

Abstract Sprouting angiogenesis is critical to blood vessel formation, but the cellular and molecular controls of this process are poorly understood. We used time-lapse imaging of green fluorescent protein (GFP)-expressing vessels derived from stem cells to analyze dynamic aspects of vascular sprout formation and to determine how the vascular endothelial growth factor (VEGF) receptor flt-1 affects sprouting. Surprisingly, loss of flt-1 led to decreased sprout formation and migration, which resulted in reduced vascular branching. This phenotype was also seen in vivo, as flt-1-/- embryos had defective sprouting from the dorsal aorta. We previously showed that loss of flt-1 increases the rate of endothelial cell division. However, the timing of division versus morphogenetic effects suggested that these phenotypes were not causally linked, and in fact mitoses were prevalent in the sprout field of both wild-type and flt-1-/- mutant vessels. Rather, rescue of the branching defect by a soluble flt-1 (sflt-1) transgene supports a model whereby flt-1 normally positively regulates sprout formation by production of sflt-1, a soluble form of the receptor that antagonizes VEGF signaling. Thus precise levels of bioactive VEGF-A and perhaps spatial localization of the VEGF signal are likely modulated by flt-1 to ensure proper sprout formation during blood vessel formation. (Blood. 2004;103:4527-4535)


Sign in / Sign up

Export Citation Format

Share Document